about
Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza SeverityHigh Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study.Economic Evaluation of Health Services Costs During Pandemic Influenza A (H1N1) Pdm09 Infection in Pregnant and Non-Pregnant Women in Spain.Effect of Occupational Exposure on A(H1N1)pdm09 Infection and Hospitalization.Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in SpainEffectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.[Risk factors of influenza (H1N1) 2009 hospitalization and effectiveness of pharmaceutical and nonpharmaceutical interventions in its prevention: a case-control study].[Differences between summer and fall waves of influenza in the pandemic of influenza (H1N1) 2009 in Navarre, Spain].[Impact of vaccination against influenza (H1N1) 2009 in Navarre: comparison of different scenarios].Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors.Benefit of conjugate pneumococcal vaccination in preventing influenza hospitalization in children: a case-control study.Predictive factors of severe multilobar pneumonia and shock in patients with influenza.Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.Different prognosis in hospitalized patients with influenza one season after the pandemic H1N1 influenza of 2009-2010 in Spain.Trends in influenza vaccine coverage among primary healthcare workers in Spain, 2008-2011.Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data.Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.Auditing the management of vaccine-preventable disease outbreaks: the need for a tool.Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study.Mortality by causes in HIV-infected adults: comparison with the general population.Evaluating the risk of HIV transmission through unprotected orogenital sex.Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000.2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study.Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.Managing an online survey about influenza vaccination in primary healthcare workers.Knowledge of and attitudes to influenza vaccination in healthy primary healthcare workers in Spain, 2011-2012Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples.Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.Effectiveness of non-pharmaceutical measures in preventing pediatric influenza: a case-control study.Comparison of body mass index (BMI) with the CUN-BAE body adiposity estimator in the prediction of hypertension and type 2 diabetes.Factors Associated with Influenza Vaccination of Hospitalized Elderly Patients in SpainCharacteristics of Hospitalized Cases of Pertussis in Catalonia and Navarra, Two Regions in the North of Spain.Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in SpainMumps outbreak in Navarre region, Spain, 2006-2007.Knowledge of and attitudes to influenza in unvaccinated primary care physicians and nurses.Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional studyModerate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE networkEffectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain.
P50
Q30377295-95C85A23-6D5D-4960-8ACB-AD63BC2F7AF8Q30379232-480DC12A-733C-4A34-8472-1C41D21CCC47Q30383860-5DE13687-EF7B-409F-A54D-1F86B294CD02Q30388833-D86A3280-9B7F-46B7-B58D-10489003F1FAQ30390702-4A1E6488-0F70-4103-A14E-1A9DE949173DQ30403059-DA39C28A-1E4F-46E6-9591-61DA2C036A31Q30404419-E04773CB-BF50-4C3F-A887-799BE718B018Q30404751-51426775-6F01-4960-899D-10FC65BFE1C5Q30404757-82683FFD-0338-4403-B784-C727B3C76215Q30404766-D0623E84-4D28-40CB-820A-75958BBD25CEQ30414878-12172463-DDAD-4139-9B5A-9791516A2399Q30426179-E7E24CE6-7FE6-4A2E-AFAD-720ACEEC7F39Q30427721-009C38F8-D1B2-4E60-9E72-D2A8094BAABAQ30429085-3D90506E-6FE0-4E1F-94F0-95B7021FC9EEQ30430185-DA90EB8F-76E8-4D60-B6D3-1C1FFBFFB092Q30431419-CFACEDF9-F16D-473F-866F-5A30C1FDA20AQ30982712-E82BAF5E-50E3-40A3-901C-B616ACC86778Q31161295-AF1E445B-4286-4F7C-B7AE-251776C1FD8FQ33797887-F986C396-D0E9-4373-A238-6D11A6BB7B50Q33853635-DDEAA06F-E2C0-48A6-AE1B-13813C06EF03Q33898621-43C29C64-402C-4DC4-976E-0A1D05289A67Q34131522-45082FBF-07D3-45B1-9C36-1594BDB1480BQ34614976-30DFE21A-BCD7-44F0-9ABC-D2DA1336BD66Q34657959-9BEAA47D-24CB-4497-A660-6356D3DD7188Q34993133-7268EE96-1B16-47E5-A0E8-5DE8E00312D2Q35015125-2EF6BBDA-387C-48D5-AFA1-8703A00CFDF3Q35049507-48E1ADCF-441E-4598-898D-2A12D85FF1EAQ35530073-E771C11E-6258-474A-8536-65ADC58A8D30Q35530514-CE0E86E3-F8B7-4BEA-8374-22832D6C26DDQ35635844-6F114B82-0A36-4379-AC67-90DF2DB17D00Q35657453-9A2EB723-B3F8-40EB-9603-542B391B5DDFQ35906106-24956D15-BE6C-4216-A618-A728225D0782Q35908258-07472710-4BA0-4879-82B5-7D968E3B34CDQ36126763-7C240383-2E7E-41F6-A5DC-BEC9464FD372Q36277159-4BE0035D-D34C-45E4-A8B7-6A45B6971B19Q36763927-9597459F-5225-4049-B5B0-CC0B2D3277AFQ36978432-3995E0A2-D4B7-408B-8D69-81AF635733ACQ37135413-F2E4A14A-4F8A-4094-BFA2-F3C0F583D6D7Q37284309-5B17C74C-9BF9-43D4-BC54-04A733A04E70Q37505437-F5D8704D-513E-416B-8549-AA32AC4F6066
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
J Castilla
@ast
J Castilla
@en
J Castilla
@es
J Castilla
@nl
J Castilla
@sl
type
label
J Castilla
@ast
J Castilla
@en
J Castilla
@es
J Castilla
@nl
J Castilla
@sl
altLabel
Jesus Castilla
@en
prefLabel
J Castilla
@ast
J Castilla
@en
J Castilla
@es
J Castilla
@nl
J Castilla
@sl
P1053
B-9048-2008
P106
P31
P496
0000-0002-6396-7265